MGMT and glioblastoma: Survival analyses (Fig. 2A) revealed that high levels of Cx43 mRNA were associated with poor prognosis of all GBM patients (All GBM), primary GBMs with promoter methylation of MGMT (MGMT–) [6], and recurrent GBMs (recurrent GBM).